Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$332,446
+$12,720 QoQ
Shares Held
1,309
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#4,073
of 4,664 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PROATHLETE WEALTH MANAGEMENT LLC holds $1,603,662 across 13 Drug Manufacturers - General names. JNJ ranks #1 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
1,309 | $332,446 | |
| 2 | PFE |
Pfizer Inc
|
12,327 | $296,833 | |
| 3 | LLY |
ELI LILLY & Co
|
232 | $278,267 | |
| 4 | ABBV |
AbbVie Inc.
|
984 | $247,613 | |
| 5 | BIIB |
Biogen Inc.
|
1,060 | $229,023 | |
| 6 | MRK |
Merck & Co., Inc.
|
956 | $122,845 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
930 | $53,586 | |
| 8 | NVS |
Novartis AG
|
162 | $25,388 |
All Filings in JNJ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $332,446 | 1,309 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $319,726 | 1,308 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $270,482 | 1,307 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $238,264 | 1,285 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $198,421 | 1,299 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $179,769 | 1,084 | Shares | Sole | 2025-04-21 | |
| No filing history on record for this holder in this stock. | ||||||